… -2 oral drugs (nirmatrelvir/ritonavir and molnupiravir), (iii) summarizes the clinical progress of
other oral antivirals for use in COVID-19, (iv… with the use of oral antivirals in clinical practice. …

… distributed oral antivirals are urgently needed to treat coronavirus disease-2019 (COVID-19), …
, and block transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…

… made in COVID-19 research and many antiviral drugs have … against COVID-19, a simple
oral antiviral drug for COVID-19 has … among COVID-19 patients with three new oral antivirals (…

… This review aims to summarize ongoing antiviral treatments in COVID-19, to discuss …
COVID-19) evaluating oral antiviral Favipiravir's at home use for mild-to-moderate COVID-19 …

… “The oral antivirals do not have the complications of the … be the most widely available antiviral
for COVID-19. Paxlovid is a … order of 50 000 doses of the antiviral—the interim results had …

… time from the start of treatment to having negative nasopharyngeal swabs (7 days in the
group receiving the triple therapy compared to 12 days in the control group receiving just oral …

… -based antiviral agents could be repurposed for COVID-19 treatment. … COVID-19 epidemic
and is potentially to be used to treat future coronavirus infections as well as other coronavirus-…

… 2 COVID-19 oral antivirals amid the peak of an outbreak with omicron variant infections in a
densely populated city. Compared with no antiviral … patients with COVID-19. Neither of the …

… New treatments are needed to reduce the risk of progression of coronavirus disease 2019
(Covid-19). Molnupiravir is an oral, small-molecule antiviral prodrug that is active against …

… —the development of oral antiviral treatment for COVID-19 still needs further study. In addition
to molnupiravir, four more oral anti-COVID-19 drugs are in phase 3 clinical trials: the 3CL …